More than 100 early-stage investments in US & EuropeMore than 75% received series A investmentHigher than 75% 5-year survival rateFollow up investment by top tier US VCs More than 200 start-up incubationParis- Saclay ‘Deep tech’ site operation (6000m2)ADN_xIFM at Station F